secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0001437749-24-021615
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences rights offering oversubscribed, raises $60M; Duggan to hold ~72%
--------------------------------------------------------------------------------

- Offering oversubscribed at 138%, receiving over $83M in subscriptions vs $60M limit.
- Expected gross proceeds of $60M from sale of ~6M units at $10/unit.
- Executive Chairman Robert Duggan subscribed for ~5M units, boosting his ownership to ~72%.
- Warrants could generate up to $66M additional proceeds if exercised; exercise price $11/share.
- Units consist of one share and two warrants; warrants expire in five years with redemption conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924021615/0001437749-24-021615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924021615/plse20240627_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-021615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer